Published in Mol Microbiol on August 01, 1997
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of Vibrio cholerae. Infect Immun (1999) 3.10
Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science (2009) 2.96
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev (2004) 1.93
Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immun (1999) 1.86
Type IV pilin proteins: versatile molecular modules. Microbiol Mol Biol Rev (2012) 1.80
Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol (2004) 1.78
Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol (2004) 1.77
Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun (2001) 1.62
Adenovirus receptors. J Virol (2005) 1.55
Extracellular bacterial pathogen induces host cell surface reorganization to resist shear stress. PLoS Pathog (2009) 1.54
The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun (2002) 1.45
Genetic analysis of membrane cofactor protein (CD46) of the complement system in women with and without preeclamptic pregnancies. PLoS One (2015) 1.42
Roles of PilC and PilE proteins in pilus-mediated adherence of Neisseria gonorrhoeae and Neisseria meningitidis to human erythrocytes and endothelial and epithelial cells. Infect Immun (1999) 1.36
Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections. Front Microbiol (2011) 1.33
Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis. J Cell Biol (2001) 1.29
Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice. Vaccine (2008) 1.26
CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cells. Infect Immun (2005) 1.22
Lipooligosaccharide-deficient Neisseria meningitidis shows altered pilus-associated characteristics. Infect Immun (2003) 1.20
Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog (2010) 1.20
Isolation of Neisseria gonorrhoeae mutants that show enhanced trafficking across polarized T84 epithelial monolayers. Infect Immun (2000) 1.19
Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol (2001) 1.16
CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. J Cell Biol (2002) 1.14
Variation of Neisseria gonorrhoeae lipooligosaccharide directs dendritic cell-induced T helper responses. PLoS Pathog (2009) 1.12
CD46 is a cellular receptor for bovine viral diarrhea virus. J Virol (2004) 1.11
Olfactory nerve--a novel invasion route of Neisseria meningitidis to reach the meninges. PLoS One (2010) 1.10
Crystal structure analysis reveals Pseudomonas PilY1 as an essential calcium-dependent regulator of bacterial surface motility. Proc Natl Acad Sci U S A (2009) 1.09
Modulation of gonococcal piliation by regulatable transcription of pilE. J Bacteriol (2001) 1.08
Localization of regions in CD46 that interact with adenovirus. J Virol (2005) 1.08
Identification of Neisseria meningitidis nonlipopolysaccharide ligands for class A macrophage scavenger receptor by using a novel assay. Infect Immun (2006) 1.07
Expression of AniA, the major anaerobically induced outer membrane protein of Neisseria gonorrhoeae, provides protection against killing by normal human sera. Infect Immun (2000) 1.06
Immunologic and structural relationships of the minor pilus subunits among Haemophilus influenzae isolates. Infect Immun (1998) 1.03
Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev (2014) 1.03
Meningococcal outer membrane protein NhhA is essential for colonization and disease by preventing phagocytosis and complement attack. Infect Immun (2008) 1.02
Targeted and restricted complement activation on acrosome-reacted spermatozoa. J Clin Invest (2005) 1.02
Neisseria gonorrhoeae pilin glycan contributes to CR3 activation during challenge of primary cervical epithelial cells. Cell Microbiol (2011) 1.01
Ultrahigh resolution and full-length pilin structures with insights for filament assembly, pathogenic functions, and vaccine potential. J Biol Chem (2011) 1.01
Effects of the immunoglobulin A1 protease on Neisseria gonorrhoeae trafficking across polarized T84 epithelial monolayers. Infect Immun (2000) 1.00
Global gene expression and the role of sigma factors in Neisseria gonorrhoeae in interactions with epithelial cells. Infect Immun (2005) 1.00
Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun (2009) 0.99
Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord (2009) 0.98
Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo. Infect Immun (2002) 0.95
Integrating host genomics with surveillance for invasive bacterial diseases. Emerg Infect Dis (2008) 0.95
Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium. Infect Immun (2010) 0.95
Pseudomonas aeruginosa PilY1 binds integrin in an RGD- and calcium-dependent manner. PLoS One (2011) 0.95
Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice. Mucosal Immunol (2011) 0.94
IFN-gamma amplifies NFkappaB-dependent Neisseria meningitidis invasion of epithelial cells via specific upregulation of CEA-related cell adhesion molecule 1. Cell Microbiol (2007) 0.93
The meningococcal minor pilin PilX is responsible for type IV pilus conformational changes associated with signaling to endothelial cells. Infect Immun (2012) 0.93
The Pathobiology of Neisseria gonorrhoeae Lower Female Genital Tract Infection. Front Microbiol (2011) 0.93
Neisseria meningitidis Opc invasin binds to the cytoskeletal protein alpha-actinin. Cell Microbiol (2008) 0.93
The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect Immun (2008) 0.92
T-cell regulation by CD46 and its relevance in multiple sclerosis. Immunology (2008) 0.92
Gonococci exit apically and basally from polarized epithelial cells and exhibit dynamic changes in type IV pili. Cell Microbiol (2006) 0.92
Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol (2005) 0.91
In vivo selection for Neisseria gonorrhoeae opacity protein expression in the absence of human carcinoembryonic antigen cell adhesion molecules. Infect Immun (2006) 0.91
Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection. J Immunol (2009) 0.91
Pathogenesis of meningococcemia. Cold Spring Harb Perspect Med (2013) 0.90
Down-regulation of CD46 by piliated Neisseria gonorrhoeae. J Exp Med (2003) 0.89
CD66 receptor specificity exhibited by neisserial Opa variants is controlled by protein determinants in CD66 N-domains. Proc Natl Acad Sci U S A (1998) 0.89
CD46 processing: a means of expression. Immunobiology (2011) 0.89
Mechanism of meningeal invasion by Neisseria meningitidis. Virulence (2012) 0.89
Monoclonal antibody detection of CD46 clustering beneath Neisseria gonorrhoeae microcolonies. Infect Immun (2006) 0.88
Neisseria gonorrhoeae mutants altered in toxicity to human fallopian tubes and molecular characterization of the genetic locus involved. Infect Immun (1999) 0.88
CD46 in innate and adaptive immunity: an update. Clin Exp Immunol (2011) 0.88
Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies. Infect Immun (2006) 0.87
Two strikingly different signaling pathways are induced by meningococcal type IV pili on endothelial and epithelial cells. Infect Immun (2011) 0.86
A SNP in intron 8 of CD46 causes a novel transcript associated with mastitis in Holsteins. BMC Genomics (2014) 0.86
Type IV pili of Neisseria gonorrhoeae influence the activation of human CD4+ T cells. Infect Immun (2006) 0.86
CD46 Contributes to the severity of group A streptococcal infection. Infect Immun (2008) 0.86
Effect of alpha-oligosaccharide phenotype of Neisseria gonorrhoeae strain MS11 on invasion of Chang conjunctival, HEC-1-B endometrial, and ME-180 cervical cells. Infect Immun (2000) 0.86
Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9. J Virol (2014) 0.86
CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines. J Virol (2005) 0.86
Structure of adenovirus type 21 knob in complex with CD46 reveals key differences in receptor contacts among species B adenoviruses. J Virol (2010) 0.85
Mutation of the conserved calcium-binding motif in Neisseria gonorrhoeae PilC1 impacts adhesion but not piliation. Infect Immun (2013) 0.84
Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding. J Neuroimmune Pharmacol (2010) 0.83
Quantitative expression analysis of HHV-6 cell receptor CD46 on cells of human cord blood, peripheral blood and G-CSF mobilised leukapheresis cells. Virol J (2006) 0.83
Cooperative role for tetraspanins in adhesin-mediated attachment of bacterial species to human epithelial cells. Infect Immun (2011) 0.82
Host-pathogen interactions in bacterial meningitis. Acta Neuropathol (2016) 0.82
Chlamydial infection increases gonococcal colonization in a novel murine coinfection model. Infect Immun (2011) 0.82
Bench-to-bedside review: genetic influences on meningococcal disease. Crit Care (2001) 0.81
Soluble pilin of Neisseria gonorrhoeae interacts with human target cells and tissue. Infect Immun (2001) 0.81
Absence of spermatozoal CD46 protein expression and associated rapid acrosome reaction rate in striped field mice (Apodemus agrarius). Reprod Biol Endocrinol (2009) 0.80
Host complement regulatory protein CD59 is transported to the chlamydial inclusion by a Golgi apparatus-independent pathway. Infect Immun (2009) 0.80
Adhesion protein ApfA of Actinobacillus pleuropneumoniae is required for pathogenesis and is a potential target for vaccine development. Clin Vaccine Immunol (2012) 0.80
Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein. PLoS One (2015) 0.79
CD46 transgenic mouse model of necrotizing fasciitis caused by Streptococcus pyogenes infection. Infect Immun (2009) 0.79
Neisseria gonorrhoeae infection induces altered amphiregulin processing and release. PLoS One (2011) 0.79
Neisseria gonorrhoeae pilus attenuates cytokine response of human fallopian tube explants. J Biomed Biotechnol (2012) 0.79
Meningococcal internalization into human endothelial and epithelial cells is triggered by the influx of extracellular L-glutamate via GltT L-glutamate ABC transporter in Neisseria meningitidis. Infect Immun (2010) 0.79
Pathogenic Neisseria hitchhike on the uropod of human neutrophils. PLoS One (2011) 0.78
Seminal plasma initiates a Neisseria gonorrhoeae transmission state. MBio (2014) 0.78
The biology of Neisseria adhesins. Biology (Basel) (2013) 0.77
Characterization of the Regulation of CD46 RNA Alternative Splicing. J Biol Chem (2016) 0.77
Impact of calcium signaling during infection of Neisseria meningitidis to human brain microvascular endothelial cells. PLoS One (2014) 0.76
CD46 plasticity and its inflammatory bias in multiple sclerosis. Arch Immunol Ther Exp (Warsz) (2011) 0.76
GP96 interacts with HHV-6 during viral entry and directs it for cellular degradation. PLoS One (2014) 0.76
Neisseria cinerea isolates can adhere to human epithelial cells by type IV pilus-independent mechanisms. Microbiology (2016) 0.75
Detection ofNeisseria Gonorrhoeae by polymerase chain reaction (PCR). Indian J Clin Biochem (1999) 0.75
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood (2006) 4.51
Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol (1991) 4.27
Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol (1989) 3.20
Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med (1976) 3.10
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med (1986) 2.94
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med (1988) 2.75
Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol (1975) 2.74
The regulators of complement activation (RCA) gene cluster. Adv Immunol (1989) 2.63
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci U S A (1987) 2.62
Control of the complement system. Adv Immunol (1996) 2.43
Polymorphism of human erythrocyte C3b/C4b receptor. Proc Natl Acad Sci U S A (1983) 2.30
Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med (1995) 2.12
Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med (1985) 2.12
Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A (1985) 2.11
Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci U S A (1994) 2.08
Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) (1977) 2.07
Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A (1995) 1.86
Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46). J Biol Chem (2000) 1.84
Molecular characterization of the Ss and Slp (C4) proteins of the mouse H-2 complex: subunit composition, chain size polymorphism, and an intracellular (PRO-Ss) precursor. J Immunol (1978) 1.75
Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med (1987) 1.74
Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest (1989) 1.70
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun (2011) 1.70
Functional properties of membrane cofactor protein of complement. Biochem J (1989) 1.68
Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J Exp Med (1984) 1.68
Intragenic variation by site-specific recombination in the cryptic plasmid of Neisseria gonorrhoeae. J Bacteriol (1986) 1.68
Decay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol (1988) 1.67
Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun (1997) 1.65
Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci U S A (1995) 1.64
Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J Immunol (1991) 1.63
Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease. Arthritis Rheum (1973) 1.61
Membrane cofactor protein (MCP; CD46): isoform-specific tyrosine phosphorylation. J Immunol (2000) 1.59
Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol (1997) 1.59
The effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes. J Clin Invest (1974) 1.58
PilC of pathogenic Neisseria is associated with the bacterial cell surface. Mol Microbiol (1997) 1.56
Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol (1988) 1.55
Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest (1974) 1.54
Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet (2001) 1.54
Induction of a transient elevation in intracellular levels of adenosine-3',5'-cyclic monophosphate by chemotactic factors: an early event in human neutrophil activation. J Immunol (1980) 1.54
Antibody-nucleic acid complexes. Immunospecific retention of globin messenger ribonucleic acid with antibodies specific for 7-methylguanosine. Biochemistry (1982) 1.52
Characterization of antibodies specific for N6-methyladenosine and for 7-methylguanosine. Biochemistry (1977) 1.49
Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol (2000) 1.48
Structure-function relationships of complement receptor type 1. Immunol Rev (2001) 1.47
Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor function. J Virol (1994) 1.46
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells. J Exp Med (1983) 1.43
Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor. J Immunol (1986) 1.41
Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement. J Immunol (1996) 1.41
The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man. J Clin Invest (1976) 1.40
Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay. Clin Exp Immunol (1991) 1.39
Genetic variation in glycosylation of the fourth component of murine complement. Association with hemolytic activity. J Biol Chem (1982) 1.39
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med (1992) 1.38
Decay-accelerating factor and membrane cofactor protein. Curr Top Microbiol Immunol (1990) 1.34
Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A (1991) 1.34
Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele. J Immunol (1985) 1.33
Improved cell surface radioiodination of macrophages. J Immunol Methods (1980) 1.30
Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. J Immunol (1998) 1.30
Cell signaling by the type IV pili of pathogenic Neisseria. J Biol Chem (1998) 1.30
The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med (1987) 1.29
A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70). J Immunol (1987) 1.28
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood (2001) 1.25
Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol (1993) 1.25
Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1. Immunopharmacology (2000) 1.25
Isolation of a biologically active macrophage receptor for the third component of complement. Nature (1981) 1.24
Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem (1994) 1.24
Pediatric and adolescent gynecology. I. Fundamental considerations. Gross anatomy. Ann N Y Acad Sci (1967) 1.24
Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. J Clin Invest (1973) 1.24
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF). J Immunol (1985) 1.23
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J Biol Chem (1999) 1.22
Diagnosis and management of hereditary angioedema (HAE). Ann Allergy (1979) 1.21
Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell Microbiol (2001) 1.21
Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci (1993) 1.20
Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b. J Biol Chem (1982) 1.19
Membrane cofactor protein. Curr Top Microbiol Immunol (1992) 1.17
Identification of a third component of complement-binding glycoprotein of human platelets. J Clin Invest (1986) 1.17
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1. J Exp Med (1988) 1.16
Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol (2001) 1.16
Structural heterogeneity of C2 Complement protein and its genetic variants in man: a new polymorphism of the HLA region. Proc Natl Acad Sci U S A (1977) 1.14
Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. J Immunol (2000) 1.14
Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A (1988) 1.14
Antibody-nucleic acid complexes. Immunospecific recognition of 7-methylguanine- and N6-methyladenine-containing 5'-terminal oligonucleotides of mRNA. J Biol Chem (1979) 1.12
The N-glycan of the SCR 2 region is essential for membrane cofactor protein (CD46) to function as a measles virus receptor. J Virol (1996) 1.12
Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem (1994) 1.12
Influence of glycosylation on allelic and cell-specific Mr variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor. J Biol Chem (1986) 1.12
Fimbriae-mediated host-pathogen cross-talk. Curr Opin Microbiol (1998) 1.12